Study of Her2/Neu Expression in 100 Cases of Uterine and Cervical Carcinoma as a Prognostic Marker

Annals of Pathology and Laboratory Medicine
doi 10.21276/apalm.1495
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Marwah Infotech

Related search

Targeting Her2/Neu in Uterine Serous Carcinoma: A Paradigm Shift in Management

Oncotarget
Oncology
2018English

HER-2/neu Expression in Cervical Intraepithelial Neoplasia and Cervical Carcinoma

International Journal of Biomedical and Advance Research
2015English

Her2/Neu Protein Expression in Colorectal Cancer

Journal of Evolution of Medical and Dental Sciences
2019English

EXPRESSION OF ER, PR AND HER2/neu IMMUNOMARKERS IN INFILTRATING DUCT CARCINOMA BREAST IN CELL BLOCK PREPARATIONS AS COMPARED TO HISTOPATHOLOGY

Journal of Evolution of Medical and Dental Sciences
2018English

A Novel Set of WNT Pathway Effectors as a Predictive Marker of Uterine Corpus Endometrial Carcinoma–Study Based on Weighted Co-Expression Matrices

Frontiers in Oncology
Cancer ResearchOncology
2019English

P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Her2/Neu Protein Expression and Oncogene Amplification in Gastric Carcinoma With Clinico-Pathological Correlation in Egyptian Patients

Open Access Macedonian Journal of Medical Sciences
Medicine
2016English

Role of PDL1 as a Prognostic Marker in Renal Cell Carcinoma: A Prospective Observational Study in Eastern India

Therapeutic Advances in Urology
Urology
2019English

Diagnostic and Prognostic Evaluation of Meningioma by IHC Markers- A Study of 100 Cases

Journal of Medical Science And clinical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy